Search results
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Finance Canada· 17 hours agoThis will lower treatment costs and burden for patients. Kisunla will be the second drug on the...
FDA approves Kisunla for early Alzheimer's treatment amid cognitive decline slowdown
BioPharma-Reporter· 5 days agoDonanemab, which will be known as Kisunla, has been given full approval by the US Food and Drug...
U.S. Regulator Approves Eli Lilly’s Alzheimer’s Drug
Baystreet· 6 days agoThe U.S. Food and Drug Administration (FDA) has approved pharmaceutical company Eli Lilly’s (LLY) Alzheimer’s drug called “Donanemab.” Eli Lilly’s medication for early-stage Alzheimer’s disease ...
FDA approves new Alzheimer’s drug that slows memory decline - National | Globalnews.ca
Global B.C.· 6 days ago“This is real progress,” said Joanne Pike of the Alzheimer’s Association. Like Eisai 4523.T and Biogen’s BIIB.O rival drug Leqembi, which was approved a year ago, donanemab ...
Factbox-Lilly follows Biogen-Eisai in securing US FDA approval for Alzheimer's drug
Reuters via Yahoo Canada News· 6 days agoKisunla is now the second drug to get a traditional approval from the U.S. regulator for the...
FDA approves Eli Lilly’s Alzheimer’s drug Kisunla
AOL· 6 days agoThe Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities in people with ...
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo Canada News· 6 days agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
FDA approves a second Alzheimer's drug that can modestly slow disease
ABC7 New York· 6 days agoU.S. officials have approved another Alzheimer's drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
Lilly's Alzheimer's drug gets FDA nod
Axios· 6 days agoThe Food and Drug Administration granted approval to Eli Lilly's Alzheimer's drug, which was found to slow progression of the disease by about a third,...
FDA Approves New Alzheimer's Drug, Adding a New Option for Treatment
Men's Journal· 6 days agoIt's the second to receive FDA approval. Alzheimer's disease affects millions of Americans as well...